13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$2.44T
+3.0% on the quarter before
Positions
7,345
650 new · 695 sold out
Top 10
24.3%
of the value
Est. gain
+$22.78B
on stocks held all quarter
Est. return
+1.1%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$31.04BAdded · 2.9% → 4.0%+251,282,045 shares
- Apple~$10.46BAdded · 2.3% → 3.1%+49,665,399 shares
- Alphabet~$4.43BAdded · 1.1% → 1.4%+24,138,286 shares
- Microsoft~$4.34BAdded · 4.6% → 4.9%+9,716,989 shares
- SPDR S&P 500 ETF TrPUT~$4.27BAdded · 0.3% → 0.5%+7,849,400 underlying
- Vanguard Total Intl Bond ETF~$3.27BAdded · 0.8% → 0.9%+67,205,744 shares
- Broadcom~$3.08BAdded · 0.7% → 1.0%+1,917,470 shares
- Select Sector SPDR TrPUT~$2.96BAdded · 0.0% → 0.1%+24,306,400 underlying
- Micron~$2.89BAdded · 0.1% → 0.3%+21,993,196 shares
- Vertiv~$2.39BAdded · 0.0% → 0.1%+27,635,362 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Alerian Mlp Index~$4.81BSold out · 0.2% → 0.0%−168,656,318 shares
- SPDR S&P 500 ETF Ser 1 S&P~$4.39BCut · 2.7% → 2.5%−8,061,808 shares
- Invesco Qqq TrPUT~$3.35BCut · 0.5% → 0.3%−6,992,600 underlying
- Progressive Corp~$3.26BCut · 0.4% → 0.2%−15,686,930 shares
- Adobe~$3.23BCut · 0.3% → 0.1%−5,819,982 shares
- Salesforce~$2.97BCut · 0.5% → 0.3%−11,561,027 shares
- Vanguard Int-Term Corporate~$2.66BCut · 0.4% → 0.3%−33,233,644 shares
- Invesco Qqq TrCALL~$2.54BCut · 0.2% → 0.1%−5,300,800 underlying
- Workday~$2.23BCut · 0.1% → 0.0%−9,952,656 shares
- Deere & Co~$1.89BCut · 0.5% → 0.3%−5,053,534 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON · shares +3.8% · price +6.2% | 4.9% | $118.72B | +$6.71B | ||||||||
| NvidiaCOMMON · shares +47% · price −4.3% | 4.0% | $96.82B | −$2.95B | ||||||||
| AppleCOMMON · shares +16% · price +22.8% | 3.1% | $76.28B | +$12.23B | ||||||||
| AmazonCOMMON · shares +0.6% · price +7.1% | 2.7% | $66.85B | +$4.42B | ||||||||
| SPDR S&P 500 ETF Ser 1 S&PCOM · shares −6.7% · price +4.0% | 2.5% | $61.31B | +$2.38B | ||||||||
| MetaCOMMON · shares +4.1% · price +3.8% | 2.2% | $52.69B | +$1.87B | ||||||||
| AlphabetCOMMON · shares +14% · price +20.5% | 1.4% | $35.31B | +$5.25B | ||||||||
| Eli LillyCOMMON · shares −2.0% · price +16.4% | 1.4% | $34.13B | +$4.80B | ||||||||
| Unitedhealth Group IncCOMMON · shares +2.1% · price +2.9% | 1.0% | $24.80B | +$694.2M | ||||||||
| MastercardCOMMON · shares +8.9% · price −8.4% | 1.0% | $24.60B | −$2.07B | ||||||||
| BroadcomCOMMON · shares +15% · price +21.1% | 0.97% | $23.66B | +$3.59B | ||||||||
| AlphabetCOMMON · shares −2.8% · price +20.7% | 0.90% | $21.82B | +$3.74B | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +18% · price −1.1% | 0.87% | $21.10B | −$190.5M | ||||||||
| Vanguard S&P 500 ETFFUND · shares −0.9% · price +4.0% | 0.86% | $21.05B | +$817.8M | ||||||||
| Ishares Core S&P 500 ETFFUND · shares −7.1% · price +4.1% | 0.84% | $20.51B | +$805.7M | ||||||||
| Exxon Mobil CorpCOMMON · shares +10% · price −1.0% | 0.84% | $20.35B | −$179.4M | ||||||||
| Abbvie IncCOMMON · shares +4.3% · price −5.8% | 0.75% | $18.37B | −$1.09B | ||||||||
| Regeneron PharmaceuticalsCOMMON · shares +7.1% · price +9.2% | 0.71% | $17.40B | +$1.37B | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +2.2% · price −3.6% | 0.62% | $15.16B | −$557.2M | ||||||||
| TSMCADR · shares +2.2% · price +27.8% | 0.60% | $14.52B | +$3.09B | ||||||||
| Eaton Corp PlcCOMMON · shares −8.2% · price +0.3% | 0.57% | $13.80B | +$38.3M | ||||||||
| Wells Fargo Co NewCOMMON · shares +1.5% · price +2.5% | 0.56% | $13.72B | +$325.6M | ||||||||
| NetflixCOMMON · shares +1.5% · price +11.1% | 0.54% | $13.11B | +$1.29B | ||||||||
| IntuitCOMMON · shares +2.0% · price +1.1% | 0.54% | $13.04B | +$140.3M | ||||||||
| AMDCOMMON · shares +2.1% · price −10.1% | 0.53% | $13.03B | −$1.44B | ||||||||
| Total · 7,345 positions | 100% | $2.44T | +$22.78B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 5,586 stocks held throughout, up $22.78B (+1.1%).
- Apple+$12.23B+23%
- Microsoft+$6.71B+6%
- Alphabet+$5.25B+20%
- Eli Lilly+$4.80B+16%
- Amazon+$4.42B+7%
- Amphenol−$1.57B−42%
- Lowes Cos Inc−$1.70B−13%
- Bristol Myers Squibb Co Com−$1.90B−23%
- Mastercard−$2.07B−8%
- Nvidia7:1 split−$2.95B−4%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 22 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |